s6y NGM BIOPHARMACEUTICALS INC EFFECT

NGM BIOPHARMACEUTICALS INC EFFECT, filed Jun 16, 2020: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 16, 2020 4:00 P.M.
Form: S-3
CIK: 0001426332
Company Name: NGM BIOPHARMACEUTICALS INC
File Number: 333-238991